Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors

Skip to primary navigation
Skip to main content
Skip to primary sidebar

About Us
Pipeline
Team
News
Join Us
Investors

About Us
Pipeline
Team
News
Join Us
Investors

Appointments Include Industry Veterans Kim Cobleigh Drapkin, CPA, and Bo Cumbo as Independent Directors WELLESLEY HILLS, Mass., April 01, 2025 (GLOBE NEWSWIRE) — Climb Bio, Inc. (Nasdaq: CLYM) today announced the appointments of biotech industry veterans Kim Cobleigh Drapkin, CPA, and Bo Cumbo to

sidebar

sidebar-alt

Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.

You will be redirected to climbbio.com

This website uses cookies to improve your experience. To learn more about information collected on our website read our Privacy Policy here.

Cookie settings ACCEPT

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-Necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT